Finance

Beta
Lists
0690:HKG
Uni-Bio Science Group Ltd
HK$0.087
+1.16%
(+0.00100) 1D
Jun 9, 10:42:31 AM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0690...
Open
HK$0.09
High
HK$0.09
Low
HK$0.09
Mkt. cap
507.95M
Avg. vol.
2.72M
Volume
120.00K
Dividend
3.60%
Quarterly dividend
HK$0.00
Ex-dividend date
Sep 2, 2013
P/E ratio
5.57
52-wk high
HK$0.17
52-wk low
HK$0.08
EPS
HK$0.02
Shares outstanding
5.97B
No. of employees
543
Open
HK$0.09
High
HK$0.09
Low
HK$0.09
Mkt. cap
507.95M
Avg. vol.
2.72M
Volume
120.00K
Dividend
3.60%
Quarterly dividend
HK$0.00
Ex-dividend date
Sep 2, 2013
P/E ratio
5.57
52-wk high
HK$0.17
52-wk low
HK$0.08
EPS
HK$0.02
Shares outstanding
5.97B
No. of employees
543
News stories
From sources across the web
About Uni-Bio Science Group Ltd
CEO-
Employees543
Founded2001
Headquarters-
SectorBiotechnology
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in HKD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
155.11M
155.11M
137.99M
137.99M
Cost of goods sold
28.07M
28.07M
21.25M
21.25M
Cost of revenue
28.07M
28.07M
21.25M
21.25M
Research and development expenses
6.82M
6.82M
13.07M
13.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
80.94M
80.94M
95.29M
95.29M
Operating expense
87.34M
87.34M
107.83M
107.83M
Total operating expenses
115.41M
115.41M
129.08M
129.08M
Operating income
39.70M
39.70M
8.91M
8.91M
Other non operating income
-
-
-915.50K
-915.50K
EBT including unusual items
39.32M
39.32M
11.44M
11.44M
EBT excluding unusual items
39.32M
39.32M
9.29M
9.29M
Income tax expense
1.35M
1.35M
2.75M
2.75M
Effective tax rate
3.43%
3.43%
24.05%
24.05%
Other operating expenses
-413.50K
-413.50K
-1.04M
-1.04M
Net income
37.98M
37.98M
8.69M
8.69M
Net profit margin
24.48%
24.48%
6.29%
6.29%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.53M
1.53M
Interest expense
-379.00K
-379.00K
-374.00K
-374.00K
Net interest expenses
-379.00K
-379.00K
1.16M
1.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
44.46M
44.46M
9.70M
9.70M
Gain or loss from assets sale
-
-
38.00K
38.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more